Leukemia Clinical Trials in Houston

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
S
A Pediatric and Young Adult Trial of Genetically Modified T Cells Directed Against CD22 for Relapsed/Refractory Leukemia or Lymphoma
Recruiting
  • Leukemia
  • Lymphoma
  • SCRI-CAR22v2
  • Los Angeles, California
  • +4 more
2022-04-02
Apr 2, 2022
C
A Study to Investigate Fadraciclib (CYC065), in Subjects With Leukemia or Myelodysplastic Syndrome (MDS)
Recruiting
  • Leukemia
  • Myelodysplastic Syndrome(MDS)
  • Duarte, California
  • +1 more
2022-04-01
Apr 1, 2022
C
A Phase 2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Myelofibrosis
Recruiting
  • Myelofibrosis
  • +13 more
  • Phoenix, Arizona
  • +54 more
2022-03-04
Mar 4, 2022
M
Phase II Eltrombopag in Chronic Lymphocytic Leukemia (CLL) - 2022
Completed
  • CLL
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2022-03-14
Mar 14, 2022
M
A Phase II Study of the Combination of Ponatinib With Mini-hyper CVD Chemotherapy and Venetoclax in Patients With Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia
Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • Leukemia
  • Houston, Texas
    MD Anderson Cancer Center
2022-03-07
Mar 7, 2022
C
Natural Killer Cell (CYNK-001) Infusions in Adults With AML
Recruiting
  • Leukemia
  • +19 more
  • CYNK-001
  • Denver, Colorado
  • +8 more
2022-03-07
Mar 7, 2022
B
A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia (CML) or With Ph+ Leukemias Resistant or Intolerant to Imatinib
Active, not recruiting
Has Results
  • Leukemia
  • Birmingham, Alabama
  • +92 more
2022-02-24
Feb 24, 2022
I
A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia
Recruiting
  • Leukemia
  • Birmingham, Alabama
  • +107 more
2022-02-22
Feb 22, 2022
P
Ibrutinib Plus Venetoclax in Subjects With Treatment-naive Chronic Lymphocytic Leukemia /Small Lymphocytic Lymphoma (CLL/SLL)
Active, not recruiting
Has Results
  • Leukemia
  • +2 more
  • Duarte, California
  • +45 more
2022-01-27
Jan 27, 2022
M
Study of Vosaroxin and Decitabine in Older Patients With Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome - 2021
Completed
Has Results
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2022-01-13
Jan 13, 2022
S
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
Active, not recruiting
Has Results
  • Leukemia
  • Birmingham, Alabama
  • +184 more
2022-02-04
Feb 4, 2022
M
Alemtuzumab or Tocilizumab in Combination With Etoposide and Dexamethasone for the Treatment of Adult Patients With Hemophagocytic Lymphohistiocytosis
Active, not recruiting
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2022-02-02
Feb 2, 2022
B
Kappa-CD28 T Lymphocytes, Chronic Lymphocytic Leukemia, B-cell Lymphoma or Multiple Myeloma, CHARKALL
Recruiting
  • Lymphoma
  • +2 more
  • Kappa CD28 T cells
  • Houston, Texas
  • +1 more
2022-01-31
Jan 31, 2022
M
Selection of Allogeneic Hematopoietic Cell Donors Based on KIR and HLA Genotypes
Active, not recruiting
  • Leukemia
  • KIR genotyping
  • HLA genotyping
  • Tampa, Florida
  • +9 more
2022-01-21
Jan 21, 2022
P
Evaluating the Feasibility of a Digital Health Coaching Program for Individuals Following CAR T Therapy
Not yet recruiting
  • Lymphoma
  • +6 more
  • Digital Health Coaching
  • Houston, Texas
    The University of Texas MD Anderson Cancer Center
2022-01-05
Jan 5, 2022
M
A Study of CPI-613 for Patients With Relapsed or Refractory Burkitt Lymphoma/Leukemia or High-Grade B-Cell Lymphoma With High-Risk Translocations
Recruiting
  • Lymphoma
  • Leukemia
  • Duarte, California
  • +9 more
2021-12-28
Dec 28, 2021
M
Fludarabine-IV Busulfan ± Clofarabine and Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) - 2020
Completed
Has Results
  • Disorder Related to Bone Marrow Transplantation
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2021-11-18
Nov 18, 2021
A
A Study Evaluating the Efficacy of Venetoclax Plus Ibrutinib in Participants With T-cell Prolymphocytic Leukemia - 2021
Completed
  • Leukemia
  • +2 more
  • Boston, Massachusetts
  • +14 more
2021-11-19
Nov 19, 2021
M
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
Recruiting
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2021-11-11
Nov 11, 2021
M
Combination of Lenalidomide and Rituximab in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL-SLL)
Active, not recruiting
  • Leukemia
  • Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2021-11-08
Nov 8, 2021
M
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
Recruiting
  • Leukemia
  • Lymphoma
  • Focus Group
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
2021-10-19
Oct 19, 2021
N
Study of PDR001 and/or MBG453 in Combination With Decitabine in Patients With AML or High Risk MDS
Active, not recruiting
  • Leukemia
  • +7 more
  • Boston, Massachusetts
  • +10 more
2021-10-14
Oct 14, 2021
M
Study of Idarubicin, Cytarabine, and Nivolumab in Patients With High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) - 2020
Completed
Has Results
  • Leukemia
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2021-09-09
Sep 9, 2021
M
Nutrition and Physical Activity Intervention in Preventing Excess Weight Gain in Pediatric Patients With Leukemia or Lymphoma Treated With Prednisone and/or Dexamethasone
Active, not recruiting
  • Leukemia
  • Lymphoma
  • Counseling
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
2021-09-17
Sep 17, 2021
B
An Investigational Immuno-therapy Study of Ulocuplumab in Combination With Low Dose Cytarabine in Patients With Newly Diagnosed Acute Myeloid Leukemia - 2019
Terminated
Has Results
  • Leukemia
  • Los Angeles, California
  • +37 more
2021-08-18
Aug 18, 2021